PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIB vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIB and ARKG is 0.79, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.8

Performance

BIB vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Nasdaq Biotechnology (BIB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
-14.54%
27.23%
BIB
ARKG

Key characteristics

Sharpe Ratio

BIB:

0.04

ARKG:

-0.59

Sortino Ratio

BIB:

0.30

ARKG:

-0.66

Omega Ratio

BIB:

1.04

ARKG:

0.93

Calmar Ratio

BIB:

0.03

ARKG:

-0.30

Martin Ratio

BIB:

0.15

ARKG:

-1.00

Ulcer Index

BIB:

9.93%

ARKG:

23.85%

Daily Std Dev

BIB:

35.51%

ARKG:

40.25%

Max Drawdown

BIB:

-67.24%

ARKG:

-80.10%

Current Drawdown

BIB:

-53.50%

ARKG:

-78.81%

Returns By Period

In the year-to-date period, BIB achieves a -9.22% return, which is significantly higher than ARKG's -27.83% return. Over the past 10 years, BIB has underperformed ARKG with an annualized return of -1.34%, while ARKG has yielded a comparatively higher 1.96% annualized return.


BIB

YTD

-9.22%

1M

-5.34%

6M

-12.71%

1Y

-1.44%

5Y*

-3.87%

10Y*

-1.34%

ARKG

YTD

-27.83%

1M

1.37%

6M

-2.83%

1Y

-26.09%

5Y*

-7.08%

10Y*

1.96%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIB vs. ARKG - Expense Ratio Comparison

BIB has a 0.95% expense ratio, which is higher than ARKG's 0.75% expense ratio.


BIB
ProShares Ultra Nasdaq Biotechnology
Expense ratio chart for BIB: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Risk-Adjusted Performance

BIB vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIB, currently valued at 0.04, compared to the broader market0.002.004.000.04-0.59
The chart of Sortino ratio for BIB, currently valued at 0.30, compared to the broader market-2.000.002.004.006.008.0010.000.30-0.66
The chart of Omega ratio for BIB, currently valued at 1.04, compared to the broader market0.501.001.502.002.503.001.040.93
The chart of Calmar ratio for BIB, currently valued at 0.03, compared to the broader market0.005.0010.0015.000.03-0.30
The chart of Martin ratio for BIB, currently valued at 0.15, compared to the broader market0.0020.0040.0060.0080.00100.000.15-1.00
BIB
ARKG

The current BIB Sharpe Ratio is 0.04, which is higher than the ARKG Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of BIB and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50JulyAugustSeptemberOctoberNovemberDecember
0.04
-0.59
BIB
ARKG

Dividends

BIB vs. ARKG - Dividend Comparison

BIB's dividend yield for the trailing twelve months is around 0.89%, while ARKG has not paid dividends to shareholders.


TTM2023202220212020201920182017
BIB
ProShares Ultra Nasdaq Biotechnology
0.89%0.07%0.03%0.00%0.00%0.00%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

BIB vs. ARKG - Drawdown Comparison

The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for BIB and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%JulyAugustSeptemberOctoberNovemberDecember
-53.50%
-78.81%
BIB
ARKG

Volatility

BIB vs. ARKG - Volatility Comparison

The current volatility for ProShares Ultra Nasdaq Biotechnology (BIB) is 11.90%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 14.47%. This indicates that BIB experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%JulyAugustSeptemberOctoberNovemberDecember
11.90%
14.47%
BIB
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab